BetterLife Pharma Inc. (CSE: BETR)
BETR trades on the Canadian Securities Exchange in Life Sciences, headquartered in British Columbia. Numbers below come from the TMX issuer list, Yahoo Finance closes and the Bank of Canada rate, each with its source.
Issuer list, sector and C$ market cap: TMX Group TSX and TSXV listed companies, as of November 13, 2026. US$ figures convert C$ at 1.4257 C$ per US$, the Bank of Canada daily rate for November 13, 2026. Close and returns: Yahoo Finance daily closes for BETR.CN, last bar 2026-11-13, computed by MarginsX. Website: sociallinks: 20-F text ("our website").
Profile
| Field | Value |
|---|---|
| Ticker | BETR on the Canadian Securities Exchange |
| Yahoo symbol | BETR.CN |
| Sector | Life Sciences, Biotechnology |
| Headquarters | British Columbia |
| Listed | The TMX list gives no listing date |
| Listing type | TMX leaves listing type blank for long-listed issuers |
| Shares outstanding | 151,896,675 |
| Also listed on | No interlisting on the TMX list |
| Index membership | Not in an S&P/TSX index per the TMX list |
| SEC CIK | 0001464165 |
| Website | www.abetterlifepharma.com |
Returns
| Window | Return |
|---|---|
| 1 day | -7.0% |
| 1 week | -11.1% |
| 1 month | -18.4% |
| 3 months | -33.3% |
| 6 months | +207.7% |
| Year to date | +300.0% |
| 1 year | +233.3% |
| From 52-week high | -52.9% |
| 52-week range | C$0.0400 to C$0.4250 |
Links
SEDAR+ is linked for searching only; nothing on this page is taken from it.
Recent Canadian filings by type
63 documents in 9 types. Each title links to the document at its source.
Annual financial statements (2)
| Document | Type | Filed |
|---|---|---|
| CONSOLIDATED FINANCIAL STATEMENTS Period 2026-01-31 | Annual financial statements (20-F) | 2026-06-01 |
| CONSOLIDATED FINANCIAL STATEMENTS Period 2025-01-31 | Annual financial statements (20-F) | 2025-06-02 |
Interim financial statements (5)
| Document | Type | Filed |
|---|---|---|
| FINANCIAL STATEMENTS Period 2026-07-31 | Interim financial statements (6-K) | 2026-09-30 |
| FINANCIAL STATEMENTS Period 2026-04-30 | Interim financial statements (6-K) | 2026-06-26 |
| FINANCIAL STATEMENTS Period 2025-07-31 | Interim financial statements (6-K) | 2025-09-29 |
| FINANCIAL STATEMENTS Period 2025-04-30 | Interim financial statements (6-K) | 2025-06-27 |
MD&A (7)
| Document | Type | Filed |
|---|---|---|
| MANAGEMENTS DISCUSSION AND ANALYSIS Period 2026-01-31 | MD&A (annual) (20-F) | 2026-06-01 |
| MANAGEMENTS DISCUSSION AND ANALYSIS Period 2025-01-31 | MD&A (annual) (20-F) | 2025-06-02 |
| MANAGEMENTS DISCUSSION AND ANALYSIS Period 2026-07-31 | MD&A (interim) (6-K) | 2026-09-30 |
| MANAGEMENTS DISCUSSION AND ANALYSIS Period 2026-04-30 | MD&A (interim) (6-K) | 2026-06-26 |
Material change report (14)
| Document | Type | Filed |
|---|---|---|
| MATERIAL CHANGE REPORT | Material change report (6-K) | 2026-09-11 |
| MATERIAL CHANGE REPORT | Material change report (6-K) | 2026-08-24 |
| MATERIAL CHANGE REPORT | Material change report (6-K) | 2026-08-05 |
| Material Change Report dated June 25, 2026 | Material change report (6-K) | 2026-06-25 |
News release (8)
| Document | Type | Filed |
|---|---|---|
| NEWS RELEASE DATED APRIL 10, 2026 | News release (6-K) | 2026-04-13 |
| NEWS RELEASE DATED APRIL 8, 2026 | News release (6-K) | 2026-04-13 |
| NEWS RELEASE DATED APRIL 2, 2026 | News release (6-K) | 2026-04-13 |
| NEWS RELEASE DATED FEBRUARY 23, 2026 | News release (6-K) | 2026-04-13 |
Management information circular / proxy (6)
| Document | Type | Filed |
|---|---|---|
| NOTICE OF ANNUAL GENERAL MEETING | Notice of meeting (6-K) | 2026-09-15 |
| NOTICE AND ACCESS | Notice of meeting (6-K) | 2026-09-15 |
| NOTICE OF ANNUAL GENERAL MEETING AND INFORMATION | Notice of meeting (6-K) | 2025-06-23 |
| NOTICE AND ACCESS | Notice of meeting (6-K) | 2025-06-23 |
Annual report (2)
| Document | Type | Filed |
|---|---|---|
| FORM 20-F Period 2026-01-31 | Annual report (20-F) (20-F) | 2026-06-01 |
| FORM 20-F Period 2025-01-31 | Annual report (20-F) (20-F) | 2025-06-02 |
Early warning / ownership (1)
| Document | Type | Filed |
|---|---|---|
| Schedule 13G | Schedule 13G (SCHEDULE 13G) | 2026-09-22 |
Certification (18)
| Document | Type | Filed |
|---|---|---|
| CEO CERTIFICATION | Certification (52-109) (6-K) | 2026-09-30 |
| CFO CERTIFICATION | Certification (52-109) (6-K) | 2026-09-30 |
| CEO CERTIFICATION | Certification (52-109) (6-K) | 2026-06-26 |
| CFO CERTIFICATION | Certification (52-109) (6-K) | 2026-06-26 |
Sources: SEC EDGAR filings (public records). Documents filed only on SEDAR+ are not copied here; search SEDAR+ for the full record.
Trading halts
No CIRO halt notices for this company in our data.
Source: Canadian Investment Regulatory Organization (CIRO), Halts/Resumptions newsroom, notices since 2024-10-15.
Upcoming events
No upcoming earnings date, call or meeting announced in the SEC filings and newswire releases we read.
Source: dates read from the company's SEC filings and newswire releases; each row links to the announcement.
US private placements (SEC Form D)
| Filed | Securities | Sold | Offered | Filing |
|---|---|---|---|---|
| 2015-12-08 | Equity | US$4.2M | US$4.2M | SEC EDGAR |
Source: SEC EDGAR Form D filings matched on SEC CIK. Amounts are US$ as filed.
Peers in Life Sciences
| Ticker | Company | Exchange | Market cap (C$) | 1 month | 1 year |
|---|---|---|---|---|---|
| ZYUS | ZYUS Life Sciences Corporation | TSXV | C$29.8M | -20.0% | -42.9% |
| NPTH | NeuPath Health Inc. | TSXV | C$31.3M | -3.6% | +30.1% |
| SONA | Sona Nanotech Inc. | CSE | C$33.2M | -15.6% | -51.8% |
| LABS | MediPharm Labs Corp. | TSX | C$27.8M | -7.1% | -7.1% |
| PINK | Perimeter Medical Imaging AI Inc. | TSXV | C$27.5M | -31.8% | -16.7% |
The app has the price chart, every filing, private raises and the full peer set for BETR.
Open in the app